Trident Lifeline Ltd. IPO

Trident Lifeline Ltd. is listed in the SME segment. The figures below are as reported by the exchanges and public sources.

Trident Lifeline Ltd. IPO — key facts

• As of 5 September 2026, the Trident Lifeline Ltd. IPO subscription status is 1.34x overall.
• The issue is open from 26-Sep-2022 to 29-Sep-2022.
• Trident Lifeline Ltd. listed on 10-Oct-2022.
• Trident Lifeline Ltd. listed at ₹108.15. The listing gain was 7.1% against the upper end of the issue price band.

Trident Lifeline Ltd. IPO details

Status

Listed

Segment

SME

Sector

Pharmaceuticals

Price

₹101

Issue size

₹35.34 Cr

Fresh issue

₹33.57 Cr

Opens

26-Sep-2022

Closes

29-Sep-2022

Listing

10-Oct-2022

Total subscription

1.34x

Retail

0.98x

NII

1.69x

Lead managers

Beeline Capital

Listing price

₹108.15

Listing day change

+7.1%

Other Pharmaceuticals IPOs

• Symbiotec Pharmalab Limited +10.9% on listing
• ABH Healthcare Limited -7.8% on listing
• Bio Medica Laboratories Limited -16.7% on listing
• Goldline Pharmaceutical Ltd. +32.0% on listing
• Sai Parenteral's Limited +3.7% on listing
• Speciality Medicines Ltd. +1.5% on listing

Live subscription, allotment status, offer documents and the full lifecycle timeline for this issue are on this page. Historical listing performance for every past IPO is in the IPO database, and each day's activity is recorded in the daily digest.

Published by INVESTOLOGY — SEBI Registered Research Analyst INH000015297. Data is reported for information only. It is not research and not investment advice. Investments in securities markets are subject to market risk; read all offer documents carefully before investing.